EuroCVP 2024 – The Annual meeting on Advances in Cardiovascular Pharmacotherapy
November 7 - November 9
On behalf of the ESC Working Group on Cardiovascular Pharmacotherapy, it is our great pleasure to invite you to attend EuroCVP 2024 – The annual scientific meeting on “Advances in cardiovascular pharmacotherapy”.
The meeting will take place in Budapest, Hungary, an international science and education hub and a cultural centre in Central Eastern Europe, on 7-9 November 2024.
EuroCVP is the official scientific meeting of the ESC Working Group on Cardiovascular Pharmacotherapy, and the focus of the programme this year will be on personalized pharmacotherapy, new advances in the prevention and treatment of cardiovascular disease. Management guidelines and the translation of recent research studies into clinical practice, will all feature prominently on the programme.
EuroCVP 2024 attracts the attention of senior and junior cardiologists, as well as internal medicine, pharmacology consultants and trainees and provide a unique opportunity to review current management guidelines, discuss new treatments and analyse the result of the most recent clinical trials on cardiovascular pharmacotherapy.
You will have the opportunity of presenting your research work at the moderated poster sessions,and enjoy a meeting that offers a vibrant scientific programme, outstanding experts and a wealth of interactive sessions. This would be a great opportunity to showcase your research work, build networks, and getting involved in the management of clinical cases and scientific discussions.
Access the Scientific programme here
Key dates
- Registration is open: Register now!
- Early fee deadline: 7 October
- Call for abstracts & Travel grant application now closed
Accreditation
This educational programme is accredited for 14 CME Credit(s).
Each participant should claim only those hours of credits that have actually been spent in the educational activity.